George Sekulich
Presidente presso EMMAUS LIFE SCIENCES, INC.
Patrimonio netto: 39 $ in data 30/06/2024
Profilo
Mr. George Sekulich is a Co-President, Director & Chief Commercial Officer at Emmaus Life Sciences, Inc. and a Chief Information Officer at EMI Holding, Inc. He is on the Board of Directors at Emmaus Life Sciences, Inc. Mr. Sekulich was previously employed as an Owner by Magellan Network Systems, Inc. He received his undergraduate degree from California State University-Dominguez Hills.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/03/2024 | 385 ( 0.00% ) | 39 $ | 30/06/2024 |
Posizioni attive di George Sekulich
| Società | Posizione | Inizio |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | Presidente | 23/08/2023 |
EMI Holding, Inc.
 EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Direttore Tecnico/Scientifico/R&S | 01/09/2014 |
Precedenti posizioni note di George Sekulich
| Società | Posizione | Fine |
|---|---|---|
| Magellan Network Systems, Inc. | Corporate Officer/Principal | - |
Formazione di George Sekulich
| California State University-Dominguez Hills | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EMMAUS LIFE SCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
| Magellan Network Systems, Inc. | |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
- Borsa valori
- Insiders
- George Sekulich
